Study guide
11.1 Pulmonary Artery Catheterization & Hemodynamic Waveform Interpretation
AACN Cardiac Medicine Certification CMC
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview and the CMC Test Plan
1.1 CMC Exam Format, Eligibility, Fees & Scoring 1.2 The CMC Test Plan: Four Domains and How to Study Them
2 Chapter 2: Acute Coronary Syndromes and Ischemic Heart Disease
2.1 Pathophysiology & Classification of Acute Coronary Syndromes 2.2 12-Lead ECG Localization & Cardiac Biomarker Trajectories 2.3 Acute Reperfusion Strategies & Nursing Management 2.4 Complications of Acute Myocardial Infarction 2.5 Chronic Coronary Disease, Hyperlipidemia and Lipid-Lowering Therapy
3 Chapter 3: Heart Failure, Cardiomyopathies, Pericardial and Valvular Disease
3.1 Acute Decompensated Heart Failure & Staging 3.2 Acute Cardiogenic Pulmonary Edema 3.3 Dilated, Hypertrophic, and Restrictive Cardiomyopathies 3.4 Acute Pericarditis, Cardiac Tamponade & Constrictive Pericarditis 3.5 Infective Endocarditis, Myocarditis and Rheumatic Heart Disease 3.6 Valvular Heart Disease: Stenosis & Regurgitation 3.7 Syncope: Cardiac Versus Non-Cardiac Causes and Workup
4 Chapter 4: Dysrhythmias, Conduction Disorders and Electrophysiologic Interventions
4.1 Atrial Fibrillation, Atrial Flutter & Supraventricular Tachycardias 4.2 Ventricular Arrhythmias & Cardiac Arrest Management 4.3 Atrioventricular Blocks & Intraventricular Conduction Delays 4.4 Temporary Pacing: Transcutaneous, Transvenous and Epicardial 4.5 Permanent Pacemakers, CRT and Device Troubleshooting 4.6 Implantable and Wearable Cardioverter Defibrillators 4.7 Catheter Ablation and Post-Ablation Nursing Care 4.8 Synchronized Cardioversion and Defibrillation
5 Chapter 5: Vascular Conditions and Vascular Interventions
5.1 Aortic Dissection, Aortic Aneurysms & Hypertensive Crises 5.2 Peripheral Artery Disease & Acute Limb Ischemia 5.3 Acute Venous Thrombosis, DVT and VTE Prophylaxis 5.4 Peripheral and Carotid Angiography and Interventions 5.5 Endovascular Aortic Repair: EVAR and TEVAR 5.6 Catheter-Directed Thrombolysis and Post-Intervention Vascular Complications
6 Chapter 6: Shock States and Mechanical Circulatory Support
6.1 Cardiogenic Shock Pathophysiology, Hemodynamics & Etiologies 6.2 Non-Cardiogenic Shock: Hypovolemic, Distributive and Obstructive 6.3 Multisystem Organ Dysfunction Syndrome 6.4 Intra-Aortic Balloon Pump Therapy & Waveform Optimization 6.5 Percutaneous & Surgical Mechanical Circulatory Support: Impella, VA-ECMO, LVAD
7 Chapter 7: Cardiac Procedures and Structural Heart Interventions
7.1 Diagnostic Cardiac Catheterization & Coronary Angiography Interpretation 7.2 Percutaneous Coronary Intervention: Stents, No-Reflow and Post-PCI Care 7.3 Structural Heart Interventions: TAVR, MitraClip, Pericardiocentesis 7.4 Post-Cardiac Surgery Management (>48 Hours) & Late Complications
8 Chapter 8: Cardiovascular Pharmacology
8.1 Inotropes, Vasopressors & Inodilators 8.2 Vasodilators & Antianginal Agents 8.3 Antiarrhythmic Agents: Vaughan Williams Classes I-IV 8.4 Anticoagulants, Antiplatelets, Thrombolytics & Reversal Agents 8.5 Diuretics and Decongestion Strategies 8.6 Guideline-Directed Medical Therapy for Heart Failure
9 Chapter 9: Non-Cardiovascular Conditions: Pulmonary
9.1 Acute Pulmonary Embolism 9.2 Acute Respiratory Failure and ARDS 9.3 Pleural Space Abnormalities: Pneumothorax, Effusion and Hemothorax 9.4 Pulmonary Hypertension and Right Ventricular Failure 9.5 Sleep-Disordered Breathing in Cardiac Patients
10 Chapter 10: Non-Cardiovascular Conditions: Endocrine, Renal, Hematologic, Neurologic and Behavioral
10.1 Diabetes Mellitus and Glycemic Control in Cardiac Care 10.2 Thyroid and Adrenal Disorders in the Cardiac Patient 10.3 Metabolic Syndrome and Cardiometabolic Risk 10.4 Coagulopathies: Heparin-Induced Thrombocytopenia, DIC and Bleeding Disorders 10.5 Anemia and Transfusion Management in Cardiac Patients 10.6 Acute Ischemic and Hemorrhagic Stroke in the Cardiac Patient 10.7 Acute Kidney Injury and Contrast-Associated Nephropathy 10.8 Chronic Kidney Disease and the Dialysis-Dependent Cardiac Patient 10.9 Electrolyte Imbalances and Dysrhythmia Risk 10.10 Substance Use, Withdrawal and Cardiac Effects 10.11 Non-Cardiac Chest Pain: Differential and Triage 10.12 Non-Cardiovascular Multisystem Complications in Cardiac Patients
11 Chapter 11: Monitoring and Diagnostics
11.1 Pulmonary Artery Catheterization & Hemodynamic Waveform Interpretation 11.2 Arterial Line Monitoring, Continuous Cardiac Output & ScvO2 11.3 Echocardiography, Cardiac MRI & Non-Invasive Cardiac Imaging 11.4 Stress Testing and Myocardial Perfusion Imaging 11.5 Remote Cardiovascular Monitoring and Ambulatory Rhythm Devices 11.6 Laboratory Testing in Cardiac Care 11.7 Arterial Blood Gases and Acid-Base Interpretation 11.8 Pulse Oximetry, Capnography and Chest Radiography
12 Chapter 12: Respiratory, Renal and Multisystem Therapeutic Interventions
12.1 Non-Invasive Ventilation in Cardiac Patients 12.2 Invasive Mechanical Ventilation and Heart-Lung Interactions 12.3 Renal Replacement Therapy: Hemodialysis, CRRT, SCUF and Ultrafiltration 12.4 Targeted Temperature Management After Cardiac Arrest 12.5 Palliative and End-of-Life Care in Advanced Cardiac Disease
11.1 Pulmonary Artery Catheterization & Hemodynamic Waveform Interpretation
Key Takeaways Explain This Topic AI
Zeroing the pressure transducer to atmospheric pressure and leveling to the phlebostatic axis (4th intercostal space, mid-axillary line) are mandatory prerequisites for accurate hemodynamic measurements.
Dynamic response testing (square wave test) evaluates system fidelity; an overdamped waveform understates systolic and overstates diastolic pressure, whereas an underdamped waveform overstates systolic and understates diastolic pressure.
Normal baseline hemodynamic pressure ranges include RA (2-6 mmHg), RV (15-30/2-8 mmHg), PA (15-30/8-15 mmHg), and PAOP (8-12 mmHg).
Pathological venous waveform alterations provide critical diagnostic clues: large v-waves signal acute mitral regurgitation, a blunted y-descent occurs in cardiac tamponade, and steep x and y descents ('W' sign) indicate constrictive pericarditis.
PAOP measurement requires strict safety protocols: balloon inflation with no more than 1.5 mL of air for a maximum duration of 10-15 seconds to prevent pulmonary artery rupture or pulmonary infarction.
Last updated: August 2026
Fundamentals of Pulmonary Artery Catheterization
Pulmonary Artery Catheterization (PAC), utilizing a balloon-tipped flow-directed catheter (Swan-Ganz catheter), remains an essential invasive bedside diagnostic modality in the Cardiac Care Unit (CCU). PAC monitoring provides continuous, real-time physiological data regarding right heart pressures, pulmonary vascular pressures, left heart filling pressures (via pulmonary artery occlusion pressure), cardiac output, and mixed venous oxygen saturation (SvO₂). These parameters guide complex therapeutic interventions in cardiogenic shock, severe heart failure, pulmonary hypertension, and post-cardiac surgery recovery.
Catheter Anatomy and Port Functions
A standard multi-lumen pulmonary artery catheter typically measures 110 cm in length and features external markings at 10 cm increments. The primary functional components include:
Distal Lumen (Yellow Port): Terminates at the catheter tip in the pulmonary artery. It measures Pulmonary Artery Systolic, Diastolic, and Mean pressures (PASP/PADP/PAMAP) as well as Pulmonary Artery Occlusion Pressure (PAOP) when the balloon is inflated. It is the exclusive site for sampling mixed venous blood (SvO₂). Safety Alert: Vasoactive drugs, continuous fluids, or hypertonic solutions must never be infused through the distal port due to the risk of direct pulmonary artery injury or bolus administration during blood sampling.
Proximal Lumen (Blue Port): Terminates 30 cm back from the catheter tip, positioning it within the Right Atrium (RA) or Superior Vena Cava (SVC). It measures Right Atrial Pressure (RAP) / Central Venous Pressure (CVP), serves as the injection port for thermal bolus cardiac output determinations, and acts as a pathway for IV fluid and medication administration.
Balloon Inflation Port (Gate Valve / Red Port): Connected to a dedicated 1.5 mL syringe with a safety lock mechanism. Inflating the balloon with air allows the catheter tip to float with venous blood flow through the right heart chambers into a terminal pulmonary artery branch to obtain PAOP.
Thermistor Wire Connector: Connects a temperature-sensitive resistor located 4 cm proximal to the catheter tip to the bedside monitor to record core body temperature and compute thermodilution cardiac output.
Optional Lumens: RV paceport for temporary transvenous pacing wires, or a continuous fiberoptic lumen for real-time SvO₂ spectrophotometry.
Insertion Procedure and Electrocardiographic Monitoring
PAC insertion is performed under strict sterile technique via central venous access (most commonly the Right Internal Jugular or Subclavian vein). Continuous single-lead ECG and real-time hemodynamic pressure tracing are mandatory throughout insertion. As the catheter is advanced through the vascular tree, characteristic pressure waveforms identify chamber location:
Right Atrium (RA): Low-pressure, low-amplitude venous waveform (normal mean 2-6 mmHg) displaying characteristic a, c, and v waves.
Right Ventricle (RV): Entered at approximately 30-35 cm from a right internal jugular or subclavian approach (the RA is reached at about 15-20 cm). Sudden transition to a high-amplitude ventricular waveform with a sharp systolic upstroke and a rapid diastolic decline to near zero (normal 15-30 / 2-8 mmHg).
Nursing Management: Transit through the RV carries a high risk of mechanically inducing premature ventricular contractions (PVCs), ventricular tachycardia (VT), or right bundle branch block (RBBB). If sustained VT occurs, the catheter must be rapidly advanced into the pulmonary artery or withdrawn back into the RA.
Pulmonary Artery (PA): Entered at approximately 35-45 cm. The systolic pressure remains identical to RV pressure, but the diastolic baseline steps up significantly above zero due to closure of the pulmonic valve, creating a distinct dicrotic notch on the downstroke (normal 15-30 / 8-15 mmHg).
Pulmonary Artery Occlusion Position (PAOP / Wedge): Achieved at approximately 45-55 cm upon inflation of the balloon. The high-amplitude PA waveform dampens into a smooth, lower-amplitude left atrial pressure tracing (normal 8-12 mmHg). Vena Cava (CVP) ──> Right Atrium (a,c,v waves) ──> Right Ventricle (Sharp upstroke, low diastole)
- │
- └──> Pulmonary Artery (Dicrotic notch) ──> PAOP Wedge (Left Atrial Reflection)
Loading diagram... Hemodynamic Waveform Progression During PAC Insertion
Technical Accuracy: Leveling, Zeroing, and Dynamic Response Testing
Inaccurate pressure measurements lead to inappropriate clinical decisions. Bedside nurses must ensure system fidelity through systematic calibration and testing protocols.
Leveling to the Phlebostatic Axis
The pressure transducer converts mechanical hydrostatic pressure from the vascular system into electrical signals displayable on the monitor. To eliminate hydrostatic forces exerted by the fluid column within the pressure tubing, the transducer air-fluid interface must be leveled to the Phlebostatic Axis .
Anatomic Location: The intersection of the 4th intercostal space (ICS) at the sternal border and a mid-axillary line (halfway between the anterior and posterior chest wall). This anatomic point corresponds directly to the location of the Right Atrium.
Patient Positioning: Leveling should be performed with the patient in the supine position with the head of the bed (HOB) elevated between 0° and 45°. If the patient's position changes, the transducer must be re-leveled.
Hydrostatic Errors: If the transducer is positioned below the phlebostatic axis, gravity adds extra hydrostatic pressure, yielding falsely high pressure readings (every 1 inch below adds ~1.8 mmHg). Conversely, if the transducer is above the phlebostatic axis, readings are falsely low .
Zeroing the System
Zeroing eliminates atmospheric pressure influence, ensuring that measured pressures represent pure intravascular values. Zeroing is accomplished by turning the transducer stopcock off to the patient, opening the side-port to atmospheric air, and pressing the "Zero" calibration button on the monitor interface. Zeroing must be performed upon initial system setup, after transducer disconnection, whenever pressure values seem clinically incongruous, and at least once per 12-hour shift.
Dynamic Response Testing (Square Wave Fast-Flush Test)
The fluid-filled tubing system possesses mechanical properties of natural frequency and damping coefficient. Evaluation is performed by activating the high-pressure fast-flush valve for 1-2 seconds and observing the resulting square wave on the monitor screen:
Optimally Damped (damping coefficient ≈ 0.6–0.7): Fast-flush produces a sharp vertical upstroke, a flat square top, followed by a sharp drop below baseline with 1 to 2 rapid oscillations (undershoots) before returning cleanly to the original pressure waveform.
Overdamped System: Characterized by a slow, rounded upstroke, absence of post-flush oscillations, and a sluggish return to baseline.
Clinical Impact: Falsely low systolic pressure and falsely high diastolic pressure (narrow pulse pressure), though mean pressure remains relatively unaffected.
Etiologies & Troubleshooting: Presence of air bubbles in tubing/transducer, blood clots in catheter lumen, compliant/soft tubing, loose connections, or excessive tubing length (>48 inches). Interventions include purging air, flushing clots, tightening stopcocks, and eliminating extra tubing/stopcocks.
Underdamped System (Hyper-resonant): Characterized by multiple sharp, sustained oscillations (>2-3 undershoots) following the square wave.
Clinical Impact: Falsely high systolic pressure and falsely low diastolic pressure (overestimated pulse pressure).
Etiologies & Troubleshooting: Excessive tubing length, rigid non-compliant tubing, catheter whipping within the PA, or hyperdynamic circulation. Interventions include using a pulse-dampening device (micro-filter) or shortening tubing length.
Hemodynamic Pressure Reference Values and Waveform Components
Mastery of normal baseline hemodynamic parameters is foundational for recognizing early acute decompensation in cardiac patients.
Normal Baseline Hemodynamic Parameters Matrix
- Parameter Abbreviation Normal Reference Range Primary Clinical Significance
- Right Atrial Pressure RAP / CVP 2 – 6 mmHg Right ventricular preload; systemic venous volume status
Right Ventricular Pressure RVP Systolic: 15–30 mmHg; Diastolic: 2–8 mmHg RV systolic performance and RV end-diastolic filling pressure
Pulmonary Artery Pressure PAP Systolic: 15–30 mmHg; Diastolic: 8–15 mmHg; Mean: 10–20 mmHg RV afterload; pulmonary vascular bed resistance and pulmonary hypertension
Pulmonary Artery Occlusion Pressure PAOP / PCWP 8 – 12 mmHg (mean) Left ventricular end-diastolic pressure (LVEDP) and LV preload
- Cardiac Output CO 4.0 – 8.0 L/min Total volume of blood pumped by heart per minute
- Cardiac Index CI 2.5 – 4.0 L/min/m² Cardiac output normalized to patient body surface area (BSA)
- Stroke Volume Index SVI 35 – 50 mL/m²/beat Volume of blood ejected per beat normalized to BSA
- Systemic Vascular Resistance SVR 800 – 1200 dyn·s·cm⁻⁵ Left ventricular afterload and peripheral vascular tone
Pulmonary Vascular Resistance PVR 50 – 250 dyn·s·cm⁻⁵ Right ventricular afterload and pulmonary arteriolar tone
Right Atrial and PAOP Waveform Analysis
Because the balloon-occluded catheter tip creates an uninterrupted fluid column from the pulmonary capillaries through the pulmonary veins and left atrium into the left ventricle during diastole, the PAOP waveform is a direct reflection of Left Atrial Pressure (LAP). Both RA and PAOP waveforms exhibit three positive wave deflections (a, c, v) and two negative descents (x, y), which correlate directly with electrical events on the ECG:
a Wave: Represents atrial contraction . Correlates timing-wise with the PR interval on ECG. It occurs at the end of diastole.
c Wave: Represents isovolumetric ventricular contraction causing closure and upward bulging of the AV valves (tricuspid/mitral) into the atrium. Correlates with the end of the QRS complex. (Often subtle or absent on PAOP tracings due to transmission delay).
x Descent: Represents atrial relaxation and the downward pulling of the AV valve floor by contracting ventricular papillary muscles during mid-systole.
v Wave: Represents passive atrial filling against closed AV valves during ventricular systole. Correlates with the end of the T wave on ECG.
y Descent: Represents rapid passive ventricular filling occurring immediately after AV valve opening at the onset of diastole.
Respiratory Variations and Measurement Rules
Intrathoracic pressure fluctuations associated with mechanical or spontaneous ventilation directly alter measured intravascular pressures:
Spontaneous Respiration: Inhalation lowers intrathoracic pressure, causing hemodynamic waveforms to dip downward; exhalation raises pressure back to baseline.
Mechanical Ventilation: Positive-pressure inhalation forces intrathoracic pressure upward, pushing waveforms higher; exhalation allows pressure to fall.
Standard Measurement Rule: All end-diastolic hemodynamic pressures (RAP, PADP, PAOP) must be measured strictly at end-expiration (the end of the respiratory cycle), when intrathoracic pressure changes are nearest to zero (atmospheric pressure).
Pathological Waveform Alterations and Clinical Diagnoses
Specific pathological cardiovascular conditions produce characteristic, high-yield waveform abnormalities on PAC tracings:
1. Large (Cannon) v Waves
Pathophysiology: Caused by massive regurgitant flow entering the atrium during ventricular contraction. In the PAOP tracing, acute Mitral Regurgitation (MR) (e.g., secondary to papillary muscle rupture following acute inferior/lateral MI) forces ventricular stroke volume backward into the left atrium during systole, creating giant, elevated v waves that can spill over onto the PA pressure tracing, masking the dicrotic notch.
Diagnostic Nuance: In acute MR, the PAOP mean reading is falsely elevated by the large v wave. To determine true LV end-diastolic filling pressure, the nurse must measure the waveform at the a wave peak or pre-v wave valley.
Right Atrial Equivalent: Large v waves on the RA/CVP tracing signify severe Tricuspid Regurgitation (TR) .
2. Cardiac Tamponade (Blunted / Absent y Descent)
Pathophysiology: Accumulation of fluid under high pressure within the rigid pericardial space causes equalization of end-diastolic pressures across all four cardiac chambers (RA = RV diastolic = PA diastolic = PAOP). Elevated intrapericardial pressure restricts ventricular expansion.
Waveform Feature: The y descent is completely blunted or absent because high intrapericardial pressure prevents rapid early diastolic ventricular filling upon AV valve opening. Conversely, the x descent remains preserved or prominent as ventricular contraction temporarily decreases heart volume within the pericardial sac.
3. Constrictive Pericarditis (Steep x and y Descents / "W" Sign)
Pathophysiology: Fibrotic thickening and calcification of the pericardium create a rigid, inelastic casing around the heart.
Waveform Feature: Characterized by steep, rapid x and y descents , creating a classic "W" or "M" pattern on the RA and PAOP tracings. The steep y descent reflects rapid, unimpeded early diastolic filling, which stops abruptly when the expanding ventricle hits the non-compliant rigid pericardium (producing the classic "square-root sign" on RV/LV pressure tracings).
PAOP Safety Protocols and Pulmonary Artery Rupture Prevention
Pulmonary Artery Occlusion Pressure measurement carries inherent risks of catastrophic complications, specifically Pulmonary Artery Rupture and Pulmonary Infarction .
Mandatory AACN Nursing Safety Rules
Volume Restriction: Never inflate the balloon with more than the maximum recommended volume ( 1.5 mL of air ). Use only the safety syringe provided with the catheter.
Resistance Monitoring: Stop inflation immediately if resistance is felt during air injection. Resistance indicates catheter tip migration into a small vessel branch; forcing inflation will rupture the artery.
Duration Restriction: Keep the balloon inflated for the absolute shortest time necessary to capture an accurate end-expiratory tracing— never exceed 10 to 15 seconds (or 2-3 respiratory cycles).
Passive Deflation: Always allow the balloon to deflate passively by unlocking the syringe plug. Never pull back forcefully on the plunger, which can damage the internal balloon membrane.
Continuous PA Monitoring: Ensure the catheter tip remains in the PA (demonstrating a distinct PA waveform with dicrotic notch) when the balloon is deflated. If spontaneous wedge occurs (continuous PAOP waveform with deflated balloon), immediately pull the catheter back until a PA tracing returns.
Managing Catastrophic PA Rupture
PA rupture presents with sudden, massive hemoptysis , rapid hemodynamic collapse, and respiratory failure. Immediate emergency interventions:
Turn the patient onto the affected side down (lateral decubitus) to protect the non-bleeding lung from blood aspiration.
Hyper-oxygenate, immediately notify the cardiac surgeon/interventionalist, prepare for emergency endotracheal intubation (often with a dual-lumen tube), and assist with immediate balloon inflation proximal to the bleeding site to achieve temporary hemostasis.